While anisomycin inhibits angiogenesis, proliferation and invasion in ovarian cancer cells by regulating the lncRNA-Meg3/miR-421/PDGFRA-Notch pathway axis48, a separate study found that lncRNA BACE1-AS is a new anisemycin target in ovarian cancer49. This evidence concerns the gene PDGFRA and ovarian carcinoma.